Voxel-wise dose rate calculation in clinical pencil beam scanning proton therapy.

Voxel-wise clinical dose pencil beam scanning proton radiotherapy rate treatments

Journal

Physics in medicine and biology
ISSN: 1361-6560
Titre abrégé: Phys Med Biol
Pays: England
ID NLM: 0401220

Informations de publication

Date de publication:
07 Feb 2024
Historique:
medline: 7 2 2024
pubmed: 7 2 2024
entrez: 7 2 2024
Statut: aheadofprint

Résumé

Clinical outcomes after proton therapy have shown some variability that is not fully understood. Different approaches have been suggested to explain the biological outcome, but none has yet provided a comprehensive and satisfactory rationale for observed toxicities. The relatively recent transition from passive scattering (PS) to pencil beam scanning (PBS) treatments has significantly increased the voxel-wise dose rate in proton therapy. In addition, the dose rate distribution is no longer uniform along the cross section of the target but rather highly heterogeneous, following the spot placement. We suggest investigating dose rate as potential contributor to a more complex proton RBE model. 
Approach. Due to the time structure of the PBS beam delivery the instantaneous dose rate is highly variable voxel by voxel. Several possible parameters to represent voxel-wise dose rate for a given clinical PBS treatment plan are detailed. These quantities were implemented in the scripting environment of our treatment planning system, and computations experimentally verified. Sample applications to treated patient plans are shown.
Main Results. Computed dose rates we experimentally confirmed. Dose rate maps vary depending on which method is used to represent them. Mainly, the underlying time and dose intervals chosen determine the topography of the resultant distributions. The maximum dose rates experienced by any target voxel in a given PBS treatment plan in our system range from ~100 to ~450 Gy(RBE)/min, a factor of 10 - 100 increase compared to PS. These dose rate distributions are very heterogeneous, with distinct hot spots.
Significance. Voxel-wise dose rates for current clinical PBS treatment plans vary greatly from clinically established practice with PS. The exploration of different dose rate measures to evaluate potential correlations with observed clinical outcomes is suggested, potentially adding a missing component in the understanding of proton RBE.

Identifiants

pubmed: 38324902
doi: 10.1088/1361-6560/ad2713
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 Institute of Physics and Engineering in Medicine.

Auteurs

Juliane Daartz (J)

Department of Radiation Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, 02114-2696, UNITED STATES.

Thomas Madden (T)

Massachusetts General Hospital, Fruit Street, Boston, Massachusetts, 02114-2696, UNITED STATES.

Arthur Lalonde (A)

Centre Hospitalier de l'Université de Montréal, 900 Saint Denis St, Montréal, Quebec, H2X 0A9, CANADA.

Ethan Cascio (E)

Department of Radiation Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts, 02114-2696, UNITED STATES.

Joost M Verburg (JM)

Department of Radiation Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts, 02114-2696, UNITED STATES.

Helen Shih (H)

Radiation Oncology, Massachusetts General Hospital, 100 Blossom St, Boston, MA 02114, USA, Boston, Massachusetts, 02114-2696, UNITED STATES.

Shannon MacDonald (S)

Department of Radiation Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts, 02114-2696, UNITED STATES.

Rachael Hachadorian (R)

Department of Radiation Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts, 02114-2696, UNITED STATES.

Jan Schuemann (J)

Department of Radiation Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts, 02114-2696, UNITED STATES.

Classifications MeSH